Agape Atp Corp

Moat Score

Market Cap $5.60M
PE -2
Debt $NaN
Cash $2.72M
EV $NaN
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$2.63M
EBIT	-$2.62M
ROE	-95%
ROA	-66%
Equity	$2.76M
Growth Stability	1
PE	-2.12
PB	2.02
P/S	4.13
Price/Cash	0.49
Net Margins	-173%
Gross Margins	62%
Op. Margins	-194%
Sales Growth YoY	-7%
Sales Growth QoQ	6%
Sales CAGR	5%
Equity CAGR	-11%
Earnings Growth YoY	57%
Earnings Growth QoQ	15%

Sales CAGR 5Y	6%
Equity CAGR 5Y	-22%
Earnings CAGR 3Y	0%
Sales CAGR 3Y	0%
Equity CAGR 3Y	1%
Market Cap	$5.60M
Revenue	$1.35M
Assets	$3.96M
Cash	$2.72M
Shares Outstanding	3.86M
Moat Score	1%
Working Capital	2.45M
Current Ratio	3.59
Gross Profit	$834.60K
Shares Growth 3y	1%
Equity Growth QoQ	-15%
Equity Growth YoY	540%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Agape ATP Corporation is a Malaysia-based investment holding company. The Company provides health and wellness products and advisory services in the Malaysian market. The Company offers three series of products: ATP Zeta Health Program, ENERGETIQUE and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to promote health and general wellbeing, as well as to prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. It ENERGETIQUE product series is comprised of ENERGETIQUE Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser. Its BEAUNIQUE product series focuses on the research of its diets impact on modifying gene expressions in order to address genetic variations and deliver a personalized nutrigenomic solution for every individual.

SEC Filings

Direct access to Agape Atp Corp (ATPC) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Agape Atp Corp compare to its competitors?

Not enough data to generate a comparison chart between Agape Atp Corp and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Agape Atp Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Agape Atp Corp Discounted Cash Flow

Fully customizable DCF calculator online for Agape Atp Corp.

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	06/2017	06/2018	12/2021	12/2022	12/2023	TTM
Net Margins	-	-27%	-248%	-91%	-147%	-173%
ROA	-	-	-39%	-55%	-37%	-66%
ROE	-	-3%	-	-108%	-48%	-95%

Bad Net Margins (-172.59%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	06/2017	06/2018	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	-	-	-	-
Debt over Equity	-	-	-	-	-	-
Growth Stability	-	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Neutral Debt/Equity ratio (-)

The company has a balance between equity and debt that is not too good nor too bad.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	06/2017	06/2018	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	-	109%	83%	-23%	6%
Earnings YoY growth	-	73%	2K%	-33%	25%	-
Equity YoY growth	-	121%	-35%	-53%	180%	-22%
FCF YoY growth	-	-	-	-	-	-